Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Alcoholic Fatty Liver Disease (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04191044
What this trial is testing

Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)

Who this might be right for
Fatty Liver Disease
Instituto de Investigación Marqués de Valdecilla 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT05464784
What this trial is testing

MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia

Who this might be right for
Diabetes Mellitus, Type 2HypertriglyceridemiaNon-Alcoholic Fatty Liver Disease
MediciNova 40
Large-scale testing (Phase 3)Study completedNCT02216552
What this trial is testing

Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents

Who this might be right for
NAFLDTYPE 2 DIABETESMETABOLIC SYNDROME
University of Manitoba 10
Not applicableLooking for participantsNCT05309863
What this trial is testing

Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease

Who this might be right for
Pediatric Non-alcoholic Fatty Liver Disease
University Hospital, Ghent 850
Not applicableStudy completedNCT02923804
What this trial is testing

Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients

Who this might be right for
Non Alcoholic Fatty Liver
Pronova BioPharma 172
Post-approval studies (Phase 4)Study completedNCT03068065
What this trial is testing

Antidiabetic Effects on Intrahepatic Fat

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Early research (Phase 1)Study completedNCT06705998
What this trial is testing

To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects

Who this might be right for
NASH
BAR Pharmaceuticals s.r.l. 43
Testing effectiveness (Phase 2)Study completedNCT04944992
What this trial is testing

Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Merck Sharp & Dohme LLC 145
Not applicableStudy completedNCT01958411
What this trial is testing

Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)

Who this might be right for
AtherosclerosisNon-alcoholic Fatty Liver Disease
Korea University 340
Not applicableStudy completedNCT06321211
What this trial is testing

Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD

Who this might be right for
Fatty Liver, Nonalcoholic
Singapore Institute of Technology 30
Not applicableStudy completedNCT04834063
What this trial is testing

Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease Patients

Who this might be right for
NAFLD
Sohag University 80
Testing effectiveness (Phase 2)UnknownNCT06302049
What this trial is testing

Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis

Who this might be right for
Fatty Liver DiseaseSteatohepatitis, Nonalcoholic
Sadat City University 46
Large-scale testing (Phase 3)Study completedNCT02242149
What this trial is testing

Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver Disease
Universidade Federal do Rio de Janeiro 84
Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Testing effectiveness (Phase 2)Study completedNCT05254626
What this trial is testing

Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Cairo University 100
Early research (Phase 1)Study completedNCT05897606
What this trial is testing

Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Sulaimani Polytechnic University 160
Not applicableLooking for participantsNCT06661655
What this trial is testing

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

Who this might be right for
Metabolic Syndrome XFatty LiverMASH - Metabolic Dysfunction-Associated Steatohepatitis+4 more
E-Scopics 120
Not applicableEnded earlyNCT01260246
What this trial is testing

Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNonalcoholic Steatohepatitis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 12
Post-approval studies (Phase 4)UnknownNCT04976283
What this trial is testing

Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic SteatohepatitisNAFLD
Getz Pharma 123
Not applicableUnknownNCT04540731
What this trial is testing

Multicenter Registry of Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hospital Italiano de Buenos Aires 2,000
Next Page